Kopp Family Office’s NeoGenomics NEO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.95M | Sell |
814,581
-13,994
| -2% | -$102K | 3.85% | 10 |
|
|
2025
Q1 | $7.86M | Hold |
828,575
| – | – | 5.44% | 7 |
|
|
2024
Q4 | $13.7M | Sell |
828,575
-98,400
| -11% | -$1.62M | 8.65% | 4 |
|
|
2024
Q3 | $13.7M | Sell |
926,975
-17,800
| -2% | -$263K | 8.71% | 4 |
|
|
2024
Q2 | $13.1M | Buy |
944,775
+50,266
| +6% | +$697K | 8.13% | 6 |
|
|
2024
Q1 | $14.1M | Sell |
894,509
-400
| -0% | -$6.29K | 8.03% | 6 |
|
|
2023
Q4 | $14.5M | Sell |
894,909
-151,730
| -14% | -$2.46M | 8.46% | 6 |
|
|
2023
Q3 | $12.9M | Buy |
1,046,639
+41,500
| +4% | +$510K | 8.15% | 6 |
|
|
2023
Q2 | $16.2M | Sell |
1,005,139
-285,880
| -22% | -$4.59M | 8.67% | 6 |
|
|
2023
Q1 | $22.5M | Sell |
1,291,019
-225,294
| -15% | -$3.92M | 12.11% | 3 |
|
|
2022
Q4 | $14M | Sell |
1,516,313
-22,800
| -1% | -$211K | 8.43% | 7 |
|
|
2022
Q3 | $13.3M | Sell |
1,539,113
-76,400
| -5% | -$658K | 10.79% | 4 |
|
|
2022
Q2 | $13.2M | Buy |
1,615,513
+1,250
| +0.1% | +$10.2K | 9.25% | 7 |
|
|
2022
Q1 | $19.6M | Buy |
1,614,263
+1,900
| +0.1% | +$23.1K | 10.6% | 5 |
|
|
2021
Q4 | $55M | Sell |
1,612,363
-173,242
| -10% | -$5.91M | 24.06% | 2 |
|
|
2021
Q3 | $86.1M | Sell |
1,785,605
-237,750
| -12% | -$11.5M | 34.19% | 1 |
|
|
2021
Q2 | $91.4M | Sell |
2,023,355
-179,810
| -8% | -$8.12M | 37.83% | 1 |
|
|
2021
Q1 | $106M | Sell |
2,203,165
-875,650
| -28% | -$42.2M | 47.22% | 1 |
|
|
2020
Q4 | $166M | Sell |
3,078,815
-154,200
| -5% | -$8.3M | 67.51% | 1 |
|
|
2020
Q3 | $119M | Sell |
3,233,015
-1,428,820
| -31% | -$52.7M | 64.78% | 1 |
|
|
2020
Q2 | $144M | Buy |
4,661,835
+3,000
| +0.1% | +$92.9K | 78.03% | 1 |
|
|
2020
Q1 | $129M | Sell |
4,658,835
-185,790
| -4% | -$5.13M | 88.3% | 1 |
|
|
2019
Q4 | $142M | Buy |
+4,844,625
| New | +$142M | 90.06% | 1 |
|